Follow Us On

Archives July 2021

Infusion bottle

New Alzheimer Drug Aducanumab Faces Controversy

The June 2021 announcement that Aducanamab –known by its shelf name Aduhelm™ -was granted FDA-accelerated approval as a treatment for Alzheimer’s disease created a flurry of excitement in families whose loved ones have been diagnosed with the terminal disease. Aduhelm is considered the first therapy to demonstrably remove amyloid plaques, one of the notorious primary

Categories

Alzheimer’s & Dementia
Behavior
Careers
Caregivers
Companion Care
COVID-19
Hospice & Palliative Care
Medication Management
Mental Health
Nutrition
Personal Care
Safety
Senior Activities
Senior Care
Uncategorized

Areas We Serve